The Role of VEGF in Intervention-Mediated Injuries: Neointimal Hyperplasia and In-Stent Restenosis. [PDF]
J Clin MedHofmann AG.
europepmc +1 more source
Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In-Stent Restenosis. [PDF]
Clin CardiolZhao B, Shen Y.
europepmc +1 more source
In-stent restenosis of left main chimney stent with successful percutaneous coronary intervention with drug-coating balloon: a case report and literature reviews. [PDF]
Eur Heart J Case RepHsieh YJ +4 more
europepmc +1 more source
Diabetes-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis. [PDF]
Clin Res CardiolKuna C +12 more
europepmc +1 more source
Smart PH-responsive drug-eluting balloons: a next-generation strategy for in-stent restenosis. [PDF]
Ann Med Surg (Lond)Ashraf A +4 more
europepmc +1 more source
Comparative outcomes of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. [PDF]
Arch Med Sci Atheroscler DisMahajan N, Singal G, Sharma M.
europepmc +1 more source
Coptis chinensis extracellular vesicles loaded with CA1-siRNA promote endothelial repair and stent restenosis therapy by regulating the PADI2 and NF-κB pathway. [PDF]
J NanobiotechnologyWang X +12 more
europepmc +1 more source
Predictive value of combined MHR and Lp(a) for in-stent restenosis in coronary heart disease patients: a study based on GEE model. [PDF]
Front Cardiovasc MedTu S, Cai M, Wang G, Zhang Z.
europepmc +1 more source
Excimer laser coronary atherectomy for treatment of recurrent in-stent restenosis complicated with no-reflow. [PDF]
Postepy Kardiol InterwencyjnejJakubowski W +5 more
europepmc +1 more source